Launch week offerEnds in00h00m00s

annual Promonthly Pro

Torkild Visnes

Has grant

Senior researcher

SINTEF

Norway

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Norway Professors in Cell Biology Cell Biology professors in Norway

Recent Grants

Grant: Close

GLIXOV

Open Date: 2024-01-01

Close Date: 2026-06-01

Grant: Open

SIP Personalised medicine

Open Date: 2023-04-01

Close Date: 2027-04-01

Grant: Close

SEP CellPaint

Open Date: 2023-01-01

Close Date: 2024-12-01

Grant: Close

Novel treatment for ROS-induced brain hypoxia-ischemia (stroke)

Open Date: 2021-01-01

Close Date:

Grant: Open

Novel treatment for neuronal reoxygenation injuries

Open Date: 2020-01-01

Close Date: 2026-12-31

Articles (11)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (6)

Ole Solheim

Professor

NORWAY

View details

Hilde Nilsen

Professor

University of Oslo

NORWAY

View details

Henri Colyn Bwanika

Karolinska Institutet

SWEDEN

View details

Christa Ringers

Norges teknisk-naturvitenskapelige universitet

NORWAY

View details

Volker Lauschke

Professor

Karolinska Institutet

SWEDEN

View details

Bård Helge Hoff

Professor

Norges teknisk-naturvitenskapelige universitet

NORWAY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Torkild Visnes

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (11)

A Classifier for Patient-Derived Colorectal Tumoroid Drug Sensitivity Using Confocal Imaging and Growth Rate Inhibition Metrics

Functional impact of Nth like DNA glycosylase 1 on mitochondrial dynamics

Model-guided discovery of MTOR-oriented synergistic drug combinations in colorectal cancer

Chemical Switching: A Concept Inspired by Strategies from Biocatalysis and Organocatalysis.

RNaseH2 inhibition potentiates temozolomide response in patient derived glioblastoma cells.

What is in a name? Rethinking SMUG1 in genome maintenance

Continuous imaging to evaluate growth and drug responses of patient-derived colorectal tumouroids

X-ray Structure of Eleven New N,N′-Substituted Guanidines: Effect of Substituents on Tautomer Structure in the Solid State

Improved Synthetic Methodology, Substrate Scope and X‐ray Crystal Structure for N, N’‐disubstituted Guanidines

Quality assessment of LNP-RNA therapeutics with orthogonal analytical techniques.

Systematic review: predictive value of organoids in colorectal cancer.

Collaborators (6)

Ole Solheim

Hilde Nilsen

Henri Colyn Bwanika

Christa Ringers

Volker Lauschke

Bård Helge Hoff

Make your next move.